Alignment Healthcare, INC Form 4 insider transactions

Alignment Healthcare's Chief Legal and Admin. Officer, Christopher J. Joyce, sold 16,187 shares of common stock to cover tax withholding obligations related to performance share unit vesting.

Alignment Healthcare's President, Dawn C. Maroney, sold 130,000 shares of common stock for approximately $2.6 million under a pre-arranged 10b5-1 trading plan.

General Atlantic (ALN HLTH), L.P. reported the sale of 11,119,494 shares of Alignment Healthcare, Inc. common stock for approximately $206.4 million.

General Atlantic, a significant shareholder and director-by-deputization, reported a planned sale of over 11 million shares of Alignment Healthcare common stock for $18.57 per share, scheduled for December 12, 2025.

Alignment Healthcare's COO, Sebastian Burzacchi, sold 12,585 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Alignment Healthcare CEO John E. Kao sold 180,000 shares of common stock for approximately $3.42 million under a pre-arranged 10b5-1 trading plan.

Alignment Healthcare's Chief Legal and Administrative Officer, Christopher J. Joyce, sold 19,706 shares of common stock for approximately $19.33 per share.

Alignment Healthcare Director Joseph S. Konowiecki sold 25,000 shares of common stock at $19 per share under a Rule 10b5-1 plan.

Alignment Healthcare Director Joseph S. Konowiecki sold 4,832 shares of common stock at $16.49 per share to cover tax withholding obligations related to restricted stock unit vesting.

Alignment Healthcare CEO John Kao sold 180,000 shares of common stock for approximately $2.94 million under a pre-arranged 10b5-1 trading plan.

Alignment Healthcare Director Joseph S. Konowiecki sold 25,000 shares of common stock for $18 per share under a pre-arranged 10b5-1 plan.

Alignment Healthcare CEO John E. Kao sold 180,000 shares of common stock for a weighted-average price of $17.286 per share under a pre-arranged 10b5-1 plan.

Alignment Healthcare's Chief Medical Officer, Hyong Kim, sold a total of 85,034 shares of common stock in two transactions in October 2025, including shares for tax obligations and under a 10b5-1 plan.

General Atlantic (ALN HLTH), L.P., a 10% owner and director, sold 6,246,096 shares of Alignment Healthcare, Inc. common stock for $16.01 per share in a private placement.

General Atlantic, a significant shareholder and director of Alignment Healthcare, Inc., has filed a Form 4 indicating a pre-planned sale of over 6.2 million shares of common stock for $16.01 per share on September 17, 2025.

Alignment Healthcare director Joseph S. Konowiecki sold 16,076 shares of common stock to cover tax obligations related to restricted stock unit vesting.

General Atlantic (ALN HLTH), L.P., a 10% owner and director of Alignment Healthcare, Inc., sold 13,460,000 shares of common stock at $16.01 per share.

General Atlantic, a significant shareholder and director, reported the sale of 13,460,000 shares of Alignment Healthcare common stock for $16.01 per share.

Alignment Healthcare's Chief Legal and Administrative Officer, Christopher J. Joyce, sold 30,939 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Alignment Healthcare's Chief Information Officer, Robert L. Scavo, sold 29,535 shares of common stock on September 10, 2025, to cover tax withholding obligations related to restricted stock unit vesting.

Alignment Healthcare's President, Dawn Christine Maroney, sold 215,662 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Alignment Healthcare Director Joseph S. Konowiecki sold 25,000 shares of common stock for $17 per share, executed under a pre-arranged 10b5-1 plan.

Alignment Healthcare CEO John E. Kao reported the sale of 535,018 shares of common stock, primarily to cover tax withholding obligations from restricted stock unit vesting and through a pre-arranged 10b5-1 plan.

Alignment Healthcare's Chief Human Resources Officer, Andreas P. Wagner, reported a planned sale of 12,032 shares of common stock at $16.47 per share.

Alignment Healthcare's Chief Medical Officer, Hyong Kim, sold 24,800 shares of common stock for $16 per share under a pre-arranged trading plan.

Alignment Healthcare's Chief Medical Officer, Hyong Kim, sold 18,600 shares of common stock for approximately $15.03 per share under a pre-arranged trading plan.

Alignment Healthcare President Dawn Maroney sold 30,000 shares of common stock for approximately $14.90 per share under a pre-arranged trading plan.

Alignment Healthcare's Chief Medical Officer, Hyong Kim, sold 18,600 shares of common stock for approximately $14.54 per share under a pre-arranged 10b5-1 trading plan.

Alignment Healthcare CEO John E. Kao sold 180,000 shares of common stock for approximately $14.60 per share under a pre-arranged 10b5-1 plan.

Alignment Healthcare's Chief Legal and Administrative Officer, Christopher J. Joyce, has filed a Form 4 indicating a future sale of 15,491 shares of common stock under a pre-arranged 10b5-1 trading plan.